Research ID
hum0348-v1Release info
Research title
Analysis of ATL progression by CD30 signaling and its biomarkers
Research overview
- Aims
- To elucidate the mechanism of the tumorigenic process involving genomic aberrations by CD30 signaling in HTLV-1-infected T-cells
- Methods
- CD30+ATL cells, CD30-ATL cells, and HTLV-1 uninfected lymphocytes were sorted by FACS AriaIII. DNA was extracted from each sorted cell and used for whole exome sequencing analysis and array-CGH analysis.
- Participants/materials
- Adult T-cell leukemia/lymphoma (ATL): 8 cases
- URL
- N/A
Datasets
| Cart | Dataset ID | Type of data | Analysis method | Access criteria | Date published |
|---|---|---|---|---|---|
| JGAD000656 | NGS (Exome) array-CGH |
| Controlled-access (Type I) | 2023-05-16 |
Data provider
- Principal investigator
- Makoto Nakashima
- Affiliation
- Graduate School of Frontier Sciences, The University of Tokyo
Research projects
No research projects.
Grants
| Name | Title | Project number |
|---|---|---|
KAKENHI Grant-in-Aid for Early-Career Scientists | Analysis of ATL progression by CD30 signaling and its biomarkers |
|
KAKENHI Grant-in-Aid for Early-Career Scientists | The oncogenic driving force of CD30 signaling-induced chromosomal instability in adult T-cell leukemia/lymphoma |
|
Related publications
| Title | DOI | Dataset ID |
|---|---|---|
The oncogenic driving force of CD30 signaling-induced chromosomal instability in adult T-cell leukemia/lymphoma |
Controlled access users
No use of the controlled access data has been recorded.